Medical Ikkou Group Co (TSE:3353) Ending Cash Position: 円5,750 Mil (As of Feb. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:3353 Medical Ikkou Group Co Ltd TSE:3353
68 GF Score
Price 円2,801.00
GF Value 円3,611.50
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Medical Ikkou Group Co Ending Cash Position?

Medical Ikkou Group Co TSE:3353 -0.46% 68 Ending Cash Position is 円5,750 Mil as of Feb. 2026. GuruFocus rates TSE:3353 with a GF Score™ of 68/100 and a GF Value™ of 円3,611.50 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Medical Ikkou Group Co's Ending Cash Position for the quarter that ended in Feb. 2026 was 円5,750 Mil.

Medical Ikkou Group Co's quarterly Ending Cash Position increased from Feb. 2025 (円-1,436 Mil) to Aug. 2025 (円8,124 Mil) but then declined from Aug. 2025 (円8,124 Mil) to Feb. 2026 (円5,750 Mil).

Medical Ikkou Group Co's annual Ending Cash Position declined from Feb. 2024 (円7,589 Mil) to Feb. 2025 (円6,639 Mil) and declined from Feb. 2025 (円6,639 Mil) to Feb. 2026 (円5,750 Mil).

Medical Ikkou Group Co Ending Cash Position Related Terms

Medical Ikkou Group Co Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Medical Ikkou Group Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medical Ikkou Group Co Ending Cash Position Chart

Medical Ikkou Group Co Annual Data
Trend Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24 Feb25 Feb26
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7,789.80 6,253.10 7,589.37 6,639.45 5,749.79

Medical Ikkou Group Co Semi-Annual Data
Aug16 Feb17 Aug17 Feb18 Aug18 Feb19 Aug19 Feb20 Aug20 Feb21 Aug21 Feb22 Aug22 Feb23 Aug23 Feb24 Aug24 Feb25 Aug25 Feb26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,044.26 8,075.43 -1,435.97 8,123.90 5,749.79
TSE:3353
68GF Score
Medical Ikkou Group Co Ltd TSE:3353
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medical Ikkou Group Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Medical Ikkou Group Co's Ending Cash Position for the fiscal year that ended in Feb. 2026 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=6639.452+-889.662
=5,750

Medical Ikkou Group Co's Ending Cash Position for the quarter that ended in Feb. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=8123.896+-2374.106
=5,750

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of 円5,750 Mil mean?
Medical Ikkou Group Co (TSE:3353) has a Ending Cash Position of 円5,750 Mil as of Feb. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Medical Ikkou Group Co and its competitors.
Is Medical Ikkou Group Co's Ending Cash Position too high?
Medical Ikkou Group Co's current Ending Cash Position is 円5,750 Mil. Overall, Medical Ikkou Group Co has a GF Score™ of 68/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medical Ikkou Group Co's Ending Cash Position compare to MMM and HON?
Medical Ikkou Group Co's Ending Cash Position of 円5,750 Mil can be compared against companies in the Conglomerates industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Conglomerates company?
A good Ending Cash Position depends on the Conglomerates industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Medical Ikkou Group Co and its competitors. Medical Ikkou Group Co's current Ending Cash Position is 円5,750 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medical Ikkou Group Co stock overvalued right now?
Based on GuruFocus' analysis, Medical Ikkou Group Co (TSE:3353) is currently considered Modestly Undervalued. The stock's GF Value™ is 円3,611.50, compared to a current price of 円2,801.00 — trading 22.4% below its estimated fair value. The current Ending Cash Position is 円5,750 Mil. Medical Ikkou Group Co's overall GF Score™ is 68/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Medical Ikkou Group Co (TSE:3353), the current Ending Cash Position is 円5,750 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medical Ikkou Group Co (TSE:3353) Overvalued in 2026?

Based on GuruFocus' analysis, Medical Ikkou Group Co stock appears to be undervalued. The current stock price of 円2,801.00 is trading 22.4% below its estimated GF Value™ of 円3,611.50. GuruFocus considers Medical Ikkou Group Co to be Modestly Undervalued.

Key valuation signals for TSE:3353:

  • Ending Cash Position: 円5,750 Mil
  • GF Value™: 円3,611.50 vs. price of 円2,801.00 (22.4% below fair value)
  • GF Score™: 68/100 with 1 warning sign

No single metric tells the full story. See the TSE:3353 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medical Ikkou Group Co Business Description

Address 501 62 Fujikata, Mie Prefecture, Tsu, JPN, 514-0815
Medical Ikkou Group Co Ltd is engaged in Dispensing pharmacy business, healthcare business, pharmaceutical wholesale business, real estate business, and investment business.
68GF Score

Get the complete analysis for TSE:3353

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円2,801.00
Price
円3,611.50
GF Value